Middle East and North Africa consensus on osteoporosis

J Musculoskelet Neuronal Interact. 2007 Apr-Jun;7(2):131-43.

Abstract

With the increasing life expectancy, osteoporosis is becoming a major worldwide health problem. The magnitude of the disease may become larger in developing countries, more particularly in the Middle East region where the prevalence of low bone mass is higher than in western countries. Although several local organizations and countries have developed guidelines for osteoporosis, no previous regional guidelines have been developed encompassing all Middle-Eastern and North African countries. The present document reviews all the regional published data on bone mineral density, risk factors, fracture prevalence and vitamin D status. It also gives simple recommendations applicable to all these countries. This document was endorsed by leading members of all the different regional countries including, Iran, Egypt, Tunisia, Jordan, Palestine, Syria, Iraq, Libya, Oman, Kuwait, Saudi Arabia and Bahrain.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Africa, Northern / epidemiology
  • Bone Density / drug effects
  • Bone Density / physiology*
  • Bone Density Conservation Agents / pharmacology
  • Bone Density Conservation Agents / therapeutic use
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism
  • Bone and Bones / physiopathology*
  • Fractures, Bone / drug therapy
  • Fractures, Bone / etiology
  • Fractures, Bone / prevention & control
  • Humans
  • Middle East / epidemiology
  • Osteoporosis / epidemiology*
  • Osteoporosis / physiopathology*
  • Osteoporosis / therapy
  • Risk Factors
  • Vitamin D Deficiency / complications
  • Vitamin D Deficiency / physiopathology
  • Vitamin D Deficiency / prevention & control

Substances

  • Bone Density Conservation Agents